NR4A1 and breast cancer: Tőkés et al. noted that breast cancer subtypes exhibit distinct lipid metabolism profiles, with hormone receptor-positive (HR+) tumors relying on a balance between fatty acid synthesis and oxidation, while TNBCs show an increased dependence on exogenous fatty acids [47].